Michael J. Barry, M.D.

Dr. Barry received an M.D. from the University of Connecticut in 1979. After a residency in internal medicine at Strong Memorial Hospital in Rochester, New York, he completed a Kaiser fellowship in general internal medicine at Harvard Medical School in 1985. He was a Kaiser Family Foundation Faculty Scholar from 1988 - 1993. He is now Director of the Health Services Research Program and Chief of the General Medicine Unit at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. Dr. Barry has been Director of the MGH Primary Care Program, President of the Society for Medical Decision-Making (SMDM), and Chair of the Eastern Section of the American Federation for Clinical Research. He is currently the President of the Society of General Internal Medicine.

Dr. Barry was the Principal Investigator of the Prostate PORT-II. He is currently PI of a project comparing screening and treatment intensity and prostate cancer mortality in the Connecticut and Seattle SEER areas. He heads the Endpoints Committee for the Prostate cancer Intervention Versus Observation Trial (PIVOT), and the Steering Committee of the Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) trial. His research interests include strategies for the evaluation and treatment of prostate disease, decision analysis, health status measurement, technology assessment, and the use of interactive media to facilitate patients’ participation in decision-making. In 1989, he was a co-winner of the Article of the Year Award from the Association for Health Services Research for a series of articles on outcomes research in benign prostatic hyperplasia.

He practices in Internal Medicine Associates at Massachusetts General Hospital, and directs the Primary Care Operations Improvement effort at MGH.